Home » Newsletters » BioWorld Science

BioWorld Science

March 14, 2003

View Archived Issues

Agents for leishmaniasis prepared and tested by Spanish team

New hypolipidemic and hypocholesterolemic agents identified by Indian researchers

New iminosugars with utility in viral infections and cancer and as immunostimulants

Schering researchers identify new urea-based NPY Y5 antagonists

Karo Bio patents new inhibitors of IK channels and their use in atrial fibrillation

Amgen researchers present new MC4 receptor agonists

Improved plasma lipid profile on ezetimibe plus lovastatin in primary hypercholesterolemia

Acambis to market Cangene's VIG product outside North America and Israel

Liposomal budesonide reduces lung inflammation in an experimental model of asthma

Kosan Biosciences receives SBIR grant to develop production method for laulimalide

Entomed and Naeja enter screening agreement for infectious diseases and cancer

Watson files Oxytrol MAA in Europe

Lorus allowed U.S. patent that protects key antisense target

Endovasc files phase III protocols for Liprostin

Interferon Sciences sells Alferon N Injection to HemispheRx

Urea-based HIV protease inhibitors identified by Pharmacor researchers

Elan and Lilly claim novel inhibitors of Abeta synthesis and/or release

Phase II/III oxypurinol study begins dosing

Patient recruitment completed in phase IIb trial of ATL-962 for obesity

Shire to develop extended-release trospium

OSI to market Novantrone in oncology indications

Enanta earns milestone in Chiron hepatitis C collaboration

Teva invests in Gamida-Cell

Micrologix Biotech updates development activities

New immunosuppressive agents isolated from soil microorganism at Japanese lab

Kaken discovers novel antifungal/cytotoxic antibiotic during screening of microbial metabolites

U.S. patent covers Chiron's NAT methods for HIV-1

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.